Teladoc (TDOC) shares crashed on July 30 as the company’s weaker-than-expected fiscal Q2 sales and muted future guidance disappointed investors.
The NYSE-listed telehealth specialist lost $0.21 on a per-share basis in its recently concluded quarter and generated $607 million in revenue, which represents a 4% year-over-year decline.